GN Store Nord A/S (CPH:GN)
Denmark flag Denmark · Delayed Price · Currency is DKK
91.88
-1.22 (-1.31%)
Jul 21, 2026, 4:59 PM CET

GN Store Nord Earnings Call Transcripts

Fiscal Year 2026

  • Q1 saw strong growth in premium headsets and gaming, but EMEA enterprise demand remained weak, impacting group revenue and margins. Guidance for 2026 is 0%-6% organic revenue growth and 8%-9% EBITA margin, with significant cost savings and shareholder returns planned post-hearing divestment.

  • M&A announcement

    The sale of the Hearing business to Amplifon for DKK 17 billion will create a global audiology leader and enable a sharper focus on technology innovation in enterprise and gaming. The deal strengthens the balance sheet, supports future growth, and is expected to close by year-end.

Fiscal Year 2025

  • 2025 saw resilient execution amid macro headwinds, with strong Hearing growth offset by Enterprise and Gaming declines. 2026 guidance targets 3%-7% organic growth and margin expansion, driven by product innovation and operational improvements.

  • Q3 saw 1% organic revenue growth, strong hearing and gaming performance, and healthy margins despite tariff headwinds. Guidance for the year is reconfirmed, with new product launches and refinancing expected to support future growth.

  • Q2 saw strong execution amid global trade and macro challenges, with Hearing up 8% organically and margin improvements across divisions. Guidance narrowed to -2% to +2% organic growth, with tariff mitigation and supply chain diversification progressing well.

  • Q1 saw mixed results with group organic revenue down 3% year-over-year, but strong launches in hearing and gaming offsetting enterprise weakness. Guidance for 2025 expects -3% to +3% organic growth and 11%-13% EBITDA margin, with proactive cost and supply chain actions mitigating tariff risks.

  • AGM 2025

    The meeting reviewed strong EBITDA growth, margin expansion, and successful debt reduction, despite mixed revenue performance and market uncertainties. Strategic focus remains on innovation, operational synergies, and achieving 2028 growth and margin targets. All proposals, including new board appointments and governance changes, were approved.

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021

Fiscal Year 2020